Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medrol effect on skeletal muscle in aging
NCT03529929Phase 3Withdrawn
- Sponsor
- Texas A&M University
- Start
- Jun 2019
- Primary completion
- May 2020
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone in inflammation, sponsored by Texas A&M University. Planned start Jun 2019; status: withdrawn.
02
Drugs
methylprednisolone
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT03529929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03529929.